Vistin Pharma ASA (OSL: VISTN)
Norway
· Delayed Price · Currency is NOK 23.40
-0.30 (-1.27%)
Jan 3, 2025, 9:00 AM CET
Vistin Pharma ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 2, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,038 | 1,033 | 701 | 859 | 774 | 461 | Upgrade
|
| Market Cap Growth | 15.29% | 47.47% | -18.47% | 11.06% | 67.79% | 39.41% | Upgrade
|
| Enterprise Value | 1,040 | 1,034 | 739 | 809 | 678 | 159 | Upgrade
|
| Last Close Price | 23.40 | 21.66 | 14.69 | 18.01 | 15.88 | 8.72 | Upgrade
|
| PE Ratio | 16.91 | 22.66 | - | 34.56 | - | 6.97 | Upgrade
|
| Forward PE | - | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 | Upgrade
|
| PS Ratio | 2.43 | 2.36 | 2.30 | 3.08 | 3.05 | 2.02 | Upgrade
|
| PB Ratio | 3.34 | 3.20 | 2.56 | 3.12 | 2.84 | 1.12 | Upgrade
|
| P/TBV Ratio | 3.98 | 3.20 | 2.56 | 3.12 | 2.84 | 1.12 | Upgrade
|
| P/FCF Ratio | 18.61 | 14.21 | - | - | - | 795.14 | Upgrade
|
| P/OCF Ratio | 12.39 | 11.41 | - | 62.82 | - | 24.36 | Upgrade
|
| PEG Ratio | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | Upgrade
|
| EV/Sales Ratio | 2.44 | 2.36 | 2.43 | 2.90 | 2.67 | 0.70 | Upgrade
|
| EV/EBITDA Ratio | 10.24 | 12.18 | 138.71 | 18.91 | 12.49 | 6.57 | Upgrade
|
| EV/EBIT Ratio | 12.58 | 15.08 | - | 24.33 | 14.89 | 9.47 | Upgrade
|
| EV/FCF Ratio | 18.65 | 14.23 | - | - | - | 273.84 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.01 | 0.18 | 0.01 | - | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.04 | 7.95 | 0.03 | - | 0.10 | Upgrade
|
| Debt / FCF Ratio | 0.15 | 0.05 | - | - | - | 4.34 | Upgrade
|
| Asset Turnover | 1.10 | 1.08 | 0.82 | 0.85 | 0.61 | 0.45 | Upgrade
|
| Inventory Turnover | 1.89 | 2.16 | 2.19 | 2.57 | 2.62 | 3.16 | Upgrade
|
| Quick Ratio | 1.06 | 1.23 | 0.62 | 1.92 | 3.38 | 5.03 | Upgrade
|
| Current Ratio | 2.13 | 2.43 | 1.35 | 3.36 | 4.39 | 5.39 | Upgrade
|
| Return on Equity (ROE) | 20.06% | 15.29% | -1.72% | 9.07% | -28.27% | 17.34% | Upgrade
|
| Return on Assets (ROA) | 13.34% | 10.58% | -1.03% | 6.34% | 6.89% | 2.09% | Upgrade
|
| Return on Capital (ROIC) | 16.57% | 13.22% | -1.27% | 7.56% | 8.27% | 2.74% | Upgrade
|
| Earnings Yield | 5.91% | 4.41% | -0.67% | 2.89% | -12.53% | 14.35% | Upgrade
|
| FCF Yield | 5.37% | 7.04% | -10.68% | -2.12% | -25.70% | 0.13% | Upgrade
|
| Dividend Yield | 4.27% | 4.62% | 5.11% | 4.16% | 3.15% | 11.47% | Upgrade
|
| Payout Ratio | 90.30% | - | - | 89.17% | - | - | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | -25.81% | Upgrade
| |
| Total Shareholder Return | 4.27% | 4.62% | 5.11% | 4.16% | 3.15% | -14.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.